Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

NCT03121820 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence, AUC, Cmax, Pharmacokinetics

Interventions

DRUG: Memantinol tablets, 20 mg
DRUG: Akatinol Memantine® tablets, 20 mg

Sponsor

Geropharm